Therespiratory diseases consistently ranking among the world’s most common health concerns, demand for mucus-clearing and airway-supportive therapies continues to grow. Patients suffering from COPD, asthma, bronchitis, cystic fibrosis, and other obstructive pulmonary conditions increasingly rely on inhalation formulations that offer fast action and direct respiratory delivery. This...